These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36891156)

  • 21. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
    Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
    Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity.
    Yamashita A; Tamaki M; Kasai H; Tanaka T; Otoguro T; Ryo A; Maekawa S; Enomoto N; de Voogd NJ; Tanaka J; Moriishi K
    Antiviral Res; 2017 Sep; 145():136-145. PubMed ID: 28827084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
    Dai XQ; Cai WT; Wu X; Chen Y; Han FM
    Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors.
    Jo E; Kim H; König A; Yang J; Yoon SK; Windisch MP
    Antiviral Res; 2021 Dec; 196():105195. PubMed ID: 34736995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
    [No Abstract]   [Full Text] [Related]  

  • 26. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
    Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
    World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
    Ueda Y; Gu W; Dansako H; Nishitsuji H; Satoh S; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 2019 Jul; 515(1):156-162. PubMed ID: 31133379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking neddylation elicits antiviral effect against hepatitis B virus replication.
    Abounouh K; Kayesh MEH; Altawalah H; Kitab B; Murakami S; Ogawa S; Tanaka Y; Dehbi H; Pineau P; Kohara M; Benjelloun S; Tsukiyama-Kohara K; Ezzikouri S
    Mol Biol Rep; 2022 Jan; 49(1):403-412. PubMed ID: 34716866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen.
    Li B; Wang Y; Shen F; Wu M; Li Y; Fang Z; Ye J; Wang L; Gao L; Yuan Z; Chen J
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect
    Choi YM; Kim H; Lee SA; Lee SY; Kim BJ
    Front Immunol; 2020; 11():652. PubMed ID: 32508804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
    Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
    J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B Gene Therapy Coming to Age.
    Soriano V
    AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection.
    Zhang K; Lai X; Song J; He L; Wang L; Ou G; Tian X; Wang L; Deng J; Zhang J; Li C; Zhuang H; Li T; Xiang K
    Antiviral Res; 2021 May; 189():105061. PubMed ID: 33705864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Zinc finger E-box-binding homeobox 2 inhibits hepatitis B virus replication and expression].
    Li XP; Hu Q; He Q; Chen WX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):824-828. PubMed ID: 27978927
    [No Abstract]   [Full Text] [Related]  

  • 39. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
    Huang H; Zhou W; Zhu H; Zhou P; Shi X
    Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient Inhibition of Hepatitis B Virus (HBV) Replication and cccDNA Formation by HBV Ribonuclease H Inhibitors during Infection.
    Chauhan R; Li Q; Woodson ME; Gasonoo M; Meyers MJ; Tavis JE
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0146021. PubMed ID: 34516242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.